Somatic point mutation calling in low cellularity tumors.
about
Recommendations for Accurate Resolution of Gene and Isoform Allele-Specific Expression in RNA-Seq Data.In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth dataWhole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.Returning individual research results for genome sequences of pancreatic cancer.Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.Whole genomes redefine the mutational landscape of pancreatic cancer.A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.Mitochondrial mutations and metabolic adaptation in pancreatic cancer.Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries.Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing.Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.Whole-genome characterization of chemoresistant ovarian cancer.A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data.Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
P2860
Q30950123-84A27332-E137-4973-A35D-4CAD3C7C2EE2Q31144037-11FE4F86-8296-4AB4-9C8C-A6A0F2424119Q33755896-711B1329-D1D3-4EB3-A1A7-69141E71313BQ33796388-12F461B4-988C-4E26-8698-AA233F0E6731Q34445264-579F50E2-49D2-4601-A3D7-48010CE47148Q34522502-21BA83C4-8278-4F00-B89B-7208AC62C649Q35602598-16F4C1FA-6AAC-40C1-AC32-4BCE99A2FBA4Q35911034-C00DCB05-EB55-4DDB-BC92-A1A71480226CQ36379244-F5806E03-1A57-4665-85DD-AB36349D3AC4Q37615978-BABE5A34-100A-44C2-8721-517A1768ABB5Q38372504-D5B67DA1-0D6D-433E-AA73-13513C2406FFQ38385463-283C0AEA-2260-4632-822E-CE3912E88C96Q38640565-26B2D180-DD4A-4A51-8384-E7893FD78389Q41460750-3C7FCA73-F71A-49C5-9FC7-B07ED34998D2Q47661008-FFE9067D-ECBB-4EA5-B80D-1ADF4DA1666FQ48221533-6C93F3A7-AF13-42EE-B10E-4E533F103680Q50272478-5225B5A0-7B6A-43F4-8070-63FF7A26D736Q55266109-71D057F8-FCA4-4037-A881-06C10AAAF08AQ57423318-1C03E35B-73BC-44BD-AF0C-35B5A1780205
P2860
Somatic point mutation calling in low cellularity tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Somatic point mutation calling in low cellularity tumors.
@en
type
label
Somatic point mutation calling in low cellularity tumors.
@en
prefLabel
Somatic point mutation calling in low cellularity tumors.
@en
P2093
P2860
P50
P1433
P1476
Somatic point mutation calling in low cellularity tumors
@en
P2093
Amber L Johns
Anita Steptoe
Anthony J Gill
Conrad Leonard
Craig Nourse
Darrin Taylor
David K Miller
Ehsan Nourbakhsh
Felicity Newell
Ivon Harliwong
P2860
P304
P356
10.1371/JOURNAL.PONE.0074380
P407
P50
P577
2013-11-08T00:00:00Z